Tag Archives: pfizer vaccine

The US multinational pharmaceutical company Pfizer has said it remains “committed to working with the Government of India to explore opportunities” to make the Pfizer-BioNTech vaccine against the novel coronavirus available in the country. In a statement, a Pfizer spokesperson said: “We are currently in discussions with many governments around …

The UK has ordered enough doses of the two-shot Pfizer-BioNTech vaccine to immunize 20 million. (Archive) Now that Britain has become the first Western country to approve a Covid-19 shot, the spotlight is on the high-risk launch. Vaccinating the nation’s roughly 67 million people will not happen overnight. The UK …

The UK today became the first country to approve the Covid-19 vaccine developed by Pfizer Inc and its German partner BioNTech SE. The vaccine will be available in Britain from next week, according to a statement from the UK government. The emergency authorization paves the way for the deployment of …

United Airlines Holdings Inc. began operating charter flights on Friday to drop doses of Pfizer Inc.’s Covid-19 vaccine for rapid distribution if the vaccines are approved by regulators, according to people familiar with the matter. The initial flights are a link in a global supply chain that is being put …

Written by Abhishek De, edited by Explained Desk | New Delhi | Updated: November 20, 2020 4:07:53 pm An actor dressed as a coronavirus reacts after injecting a fantasy vaccine during a street performance in Plaza San Martín (AP) Encouraging results in Covid-19 vaccine trials by pioneers in November have …

Dr Randeep Guleria, Director of the All India Institute of Medical Sciences (AIIMS) Delh, said today that India is in talks with the Pfizer-BioNTech Covid-19 vaccine, but not so much with Moderna’s candidate vaccine. Speaking at the 18th Hindustan Times Leadership Summit (HTLS), 2020, Guleria answered a series of questions …

The biotech company Pfizer said Wednesday that a full study of its experimental COVID-19 The vaccine was shown to be 95% effective. Pfizer said the vaccine did not have serious side effects and that the company will request emergency use authorization from US regulators in a matter of days. “The …

Pfizer Inc. and BioNTech SE announced Wednesday that the final efficacy analysis of their vaccine candidate, BNT162b2, undergoing the phase 3 trial met all of the study’s primary efficacy endpoints. Biotech companies said the study indicated a 95 percent vaccine efficacy rate, close to the efficacy rate found in early …

By: Reuters | Updated: November 18, 2020 8:21:33 pm The drugmaker said the efficacy of the vaccine, developed with German partner BioNTech SE, was consistent across age and ethnic demographics. Pfizer Inc said Wednesday that final results of the last stage of the trial of its Covid-19 vaccine show that …

Pfizer Inc. said a final analysis of data from clinical trials showed that its Covid-19 vaccine was 95% effective, paving the way for the company to apply for the first U.S. regulatory clearance for a vaccine against the coronavirus in a few days. US drugmaker and partner BioNTech SE said …